Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Changes to the Chilean location listing replace regional labels in Spanish with corresponding region labels in English, while preserving the same locations and site identifiers (e.g., Temuco and Viña del Mar). The page revision/version string was updated accordingly.
    Difference
    0.5%
    Check dated 2026-04-27T07:38:21.000Z thumbnail image
  2. Check
    16 days ago
    No Change Detected
  3. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:53:03.000Z thumbnail image
  4. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T01:47:39.000Z thumbnail image
  5. Check
    73 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T12:48:18.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1, which appears to be a minor metadata update rather than a change to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T09:01:09.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Show glossary feature added and several administrative labels updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data). Revision tag updated to Revision: v3.4.0, replacing v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-24T06:09:11.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.